Enzyme-Linked Immuno-Sorbent Assay (ELISA)
Mechanism: The basic mechanism involved in these test utilizes absorption of antigen to a solid substrate which is placed in contact with a dilution of serum. The reaction which detects and quantifies the binding of antibody uses an antibody labeled with an enzyme followed by the addition of an appropriate substrate on which the enzyme can act to produce a colour reaction. Two distinct test mechanisms are used which we will designate "standard" and "competitive". These are described in detail under "Methods" below.
Reagents: Antigens may be produced using any of the standard techniques. They may be purified by precipitation and ultra-centrifugation or by column chromatography before being absorbed onto the surface. An alternative method which allows the use of relatively impure antigens is to bind specific antibody to the surface and allow it to absorb the antigen from the preparation. Since the latter approach usually adds an extra stage to the test this is not the preferred approach for commercial test kits. In most cases the antigen is delivered pre-absorbed onto plates, though they need to be carefully dried and packed to maintain their stability at refrigerator temperature for a reasonable period. The labeled anti-globulin used in the standard test is included in the test kits as is the appropriate substrates and stop-solutions for use with it. All of these reagents may be purchased separately from a number of sources however their titration to a standard level of activity for a specific purpose is rarely worthwhile for a commercial laboratory carrying out routine serology. Finally, and most importantly, standard negative sera and positive sera of known potency are required. These are even more important than those used in other serological tests since it is common practice to express the results of the test sera by comparing them with those of the control sera (serum-to-positive or serum-to-negative ratios). The objective of this is to remove some of the variation due to operator, environment and plate effects.
Methods:A. Standard. The antigen is absorbed on to a suitable physical surface. Usually this will be the well walls of a polystyrene micro-titre plate, although other surfaces have also been used (Rivetz et alii, 1985). A test-serum dilution (usually between 1:100 and 1:500) is made in a special diluent designed to inhibit non-specific binding of globulins to the physical surface but allowing their binding to the absorbed antigen. A range of tests can be carried out using a single serum dilution (Snyder et alii, 1984). The diluted serum is removed and the surface washed before adding an chicken anti-globulin labeled with an enzyme (usually a phosphatase). The anti-globulin will bind to any globulin attached to the antigen. Once again the excess reagent is removed and the surface washed before adding the enzyme substrate. Any attached enzyme-labeled conjugate causes a chemical change in the substrate which results in a colour change. The enzyme is inactivated after a fixed incubation time to stop the reaction, before reading the results using a colourimeter (Figure 2.7).
B. Competitive. The first part of this mechanism is very similar to the standard test in that antigen is absorbed on the solid surface and a serum dilution is applied. Serum dilutions tend to be much lower however (typically 1:2). The difference lies in the use of a standard anti-antigen conjugate to bind to any antigen sites which have not been bound to by the serum antibody as opposed to the anti-globulin in the standard test which binds to attached antibody. The addition of substrate, stop solution and reading is for the standard test. The interpretation is the opposite of the standard test in that a lack of colour development is indicative of a positive reaction.\par Statistical methods have been developed for the conversion of serum-to-positive ratios into serum titres (Chalquest, R.R., 1988, Briggs et alii, 1986)
Comments: An Elisa for Infectious Bursal Disease (IBD) has been found to be up to 25000 times more sensitive than DID/AGP (Marquardt et alii, 1980). Since 2 attachment sites are not required for the globulin to attach to the antigen this test can detect "incomplete" antibody in the same way as the Coombes test.

Figure 2.7. Micro-titre plate with a standard Elisa test seen from below. The first 2 wells at top right are the negative controls. The following 2 are positive controls. The remaining sera are field test sera. Usually at least 2 wells with a known laboratory positive control are included on each plate.
Assays: A large numbers of different assays based on Elisa technology have been developed for the detection and quantification of antibody response of poultry. A somewhat smaller number of assays are available commercially. See Table 3 for a list of assays and references.
| Table 3. A list of poultry diseases for which Elisa tests have been developed for antibody detection. Most of the references deal with non-commercial tests. Commercial kit suppliers are shown in the right-hand column. The assay type is designated as Comp. for Competitive, all others are Standard (see discussion under Methods). | ||
| Assay/Disease | Reference | Kit Manufacturer |
| Chickens | ||
| Avian Encephalomyelitis | Garrett et alii, 198 | IDEXX, KPL |
| Smart & Grix, 198 | ||
| Avian Influenza | Snyder et alii, 1985 | |
| Meulemans et alii, 1987 | ||
| Avian Leukosis | Tsukamoto et alii, 1985 | IDEXX |
| Avian Rhinotracheitis | Chettle et alii, 1990 | Cambridge Veterinary Sciences |
| Eterradossi et alii, 1992 | Svanova Biotech (Comp.) | |
| Guildhay | ||
| Bordetella avium | Hopkins et alii, 1988 | |
| Egg Drop Syndrome | Guildhay | |
| Fowl Cholera P.multocida | Briggs & Skeeles, 1984 | IDEXX,KPL |
| Avakian and Dick, 1985 | ||
| Briggs et alii, 1985 | ||
| Avakian et alii, 1986 | ||
| Fowl Pox | Buscaglia, 1985 | |
| Chick Anaemia Virus | Todd et alii, 1990 | Guildhay |
| Goodwin et alii, 1992 | ||
| Lamichane et alii, 1992 | ||
| Coccidiosis | Carlson, 1984 | |
| Onaga et alii, 1986 | ||
| Infectious Bronchitis | Piela et alii, 1984 | IDEXX,KPL |
| Snyder et alii, 1984 | ||
| Zellen and Thorsen, 1986 | ||
| Thayer et alii, 1987 | ||
| Martins et alii, 1991 | ||
| Monreal et alii, 1985 | ||
| Infectious Bursal Disease | Snyder et alii, 1984 | IDEXX,KPL |
| Solano et alii, 1985 | Guildhay | |
| Briggs et alii, 1986 | ||
| Solano et alii, 1986 | ||
| Tsukamoto et alii,1990 | ||
| Inf. Laryngotracheitis | Adair et alii, 1985 | KPL |
| Leucocytozoonosis | Isobe and Suzuki, 1986 | |
| Marek's Disease | Cheng et alii, 1984 | |
| Mycoplasma gallisepticum | Piela et alii, 1984 | IDEXX |
| Talkington et alii, 1985 | KPL | |
| Higgins and Whitear, 1986 | ||
| Mohammed et alii, 1986a, | ||
| Yagihashi et alii, 1986 | ||
| Avakian et alii, 1988 | ||
| Cummins et alii, 1990 | ||
| Mycoplasma synoviae | Higgins and Whitear, 1986 | IDEXX (+ M.g.) |
| Mohammed et alii, 1986a,b | KPL | |
| Newcastle Disease | Piela et alii, 1984 | IDEXX |
| Snyder et alii, 1984 | Guildhay | |
| Wilson et alii, 1984 | Immuno-Comb | |
| Marquardt et alii, 1985 | KPL | |
| Rivetz et alii, 1985 | ||
| Thayer et alii, 1987a,b | ||
| Brown et alii, 1990 | ||
| Rotavirus | Myers et alii, 1989 | |
| Reovirus | Islam & Jones, 1988 | IDEXX,KPL |
| Reticuloendotheliosis | IDEXX | |
| Salmonella typhimurium | Hassan et alii,1990,1991,1993 | Guildhay |
Salmonella enteritidis |
Keller et alii, 1993 |
Guildhay |
| Cooper et alii, 1989 | IDEXX (Comp.) | |
| .......................................................... | Hassan et alii, 1990....................... | ....................................................... |
| Dadrast et alii, 1990 | ||
| Timoney et alii, 1990 | ||
| Nicholas & Andrews, 1991 | ||
| Nicholas & Cullen, 1991 | ||
| S.gallinarum/pullorum | Barrow et alii, 1992 | |
| Escherichia coli | Leitner et alii, 1989 | |
| Melamed et alii, 1991 | ||
| Turkeys | ||
| Enterovirus | Hayhow and Saif, 1993 | |
| Haemorrhagic enteritis | Ionconescu, 1984 | |
| (Adenovirus Type II) | Davidson et alii, 1985 | |
| Ionconescu et alii, 1985b | ||
| Hurk and V.d.Hurk, 1986 | ||
| Paramyxovirus type 3 | Ionconescu et alii, 1985a | |
| Rotavirus | Kang et alii, 1985 | |
| Mycoplasma synoviae | Ortiz and Kleven, 1992 | |
| Mycoplasma iowae | Jordan et alii, 1987 | |
| Newcastle Disease | IDEXX | |
| Pasteurella multocida | IDEXX | |
| Other birds | ||
| Ornithosis (Chlamydia) | Ruppanner et alii, 1984 | |
| Pasteurella anatipestifer | Hatfield et alii, 1987 |
Note: No endorsement is intended by citing specific manufacturers in the above list. For an up-to-date list of ucts please contact the manufacturer direct:
| Cambridge Veterinary Sciences Unit 8, Henry Crabb Road Littleport, Ely Cambs\tab CB16 1SE UK Tel +44 (0) 353 861911 Fax 860409 |
KPL Kirkegaard & Perry Laboratories 3 Cessna Court Gaithersburg Maryland 20879-4174 USA Tel +1 301 948 7755 Fax 9480169 |
| Guildhay Ltd Riverside Business Centre Walnut Tree Close Guildford Surrey GU1 4UG United Kingdom Tel +44 (0) 483 573727 Fax 574828 |
Svanova Biotech S-751 83 Uppsala Sweden T. 46 18 557055 Fax 46 18 553398 |
| IDEXX Laboratories Ltd Milton Court, Churchfield Road Chalfont St Peter, Nr Gerrards Cross SL9 9EW United Kingdom Tel +44 (0) 753 891660 Fax 891520 |
........................................................... |